WCN26-8553 Thrombotic Microangiopathy After Kidney Transplantation: A Retrospective Cohort Study

Read full text Summarise with VIRAT
Authors: Mayara Lopes Bechuate, M. Cunha, José Otto Reusing, David Machado, Elias Elias, María Cristina Castro
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Thrombotic microangiopathy (TMA) is a severe condition involving microthrombi formation, platelet consumption, hemolytic anemia, and tissue ischemia. The kidney is particularly vulnerable due to the fragility of the glomerular endothelium, making TMA a major cause of graft dysfunction after kidney transplantation. It may present with hemolytic anemia, thrombocytopenia, and acute kidney injury, but is sometimes detected only on histopathology. Post-transplant TMAs are classified as de novo when no episodes of TMA were diagnosed previously or recurrent.

Fields of Study & Subjects

Complement system in diseases Renal Transplantation Outcomes and Treatments Renal Diseases and Glomerulopathies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105557–105557
Publication date
25 March 2026
Language
EN